Literature DB >> 22434537

Nasal insulin changes peripheral insulin sensitivity simultaneously with altered activity in homeostatic and reward-related human brain regions.

M Heni1, S Kullmann, C Ketterer, M Guthoff, K Linder, R Wagner, K T Stingl, R Veit, H Staiger, H-U Häring, H Preissl, A Fritsche.   

Abstract

AIMS/HYPOTHESIS: Impaired insulin sensitivity is a major factor leading to type 2 diabetes. Animal studies suggest that the brain is involved in the regulation of insulin sensitivity. We investigated whether insulin action in the human brain regulates peripheral insulin sensitivity and examined which brain areas are involved.
METHODS: Insulin and placebo were given intranasally. Plasma glucose, insulin and C-peptide were measured in 103 participants at 0, 30 and 60 min. A subgroup (n = 12) was also studied with functional MRI, and blood sampling at 0, 30 and 120 min. For each time-point, the HOMA of insulin resistance (HOMA-IR) was calculated as an inverse estimate of peripheral insulin sensitivity.
RESULTS: Plasma insulin increased and subsequently decreased. This excursion was accompanied by slightly decreased plasma glucose, resulting in an initially increased HOMA-IR. At 1 h after insulin spray, the HOMA-IR subsequently decreased and remained lower up to 120 min. An increase in hypothalamic activity was observed, which correlated with the increased HOMA-IR at 30 min post-spray. Activity in the putamen, right insula and orbitofrontal cortex correlated with the decreased HOMA-IR at 120 min post-spray. CONCLUSIONS/
INTERPRETATION: Central insulin action in specific brain areas, including the hypothalamus, may time-dependently regulate peripheral insulin sensitivity. This introduces a potential novel mechanism for the regulation of peripheral insulin sensitivity and underlines the importance of cerebral insulin action for the whole organism.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22434537     DOI: 10.1007/s00125-012-2528-y

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  50 in total

1.  Intranasal insulin improves memory in humans.

Authors:  Christian Benedict; Manfred Hallschmid; Astrid Hatke; Bernd Schultes; Horst L Fehm; Jan Born; Werner Kern
Journal:  Psychoneuroendocrinology       Date:  2004-11       Impact factor: 4.905

2.  The cerebrocortical response to hyperinsulinemia is reduced in overweight humans: a magnetoencephalographic study.

Authors:  Otto Tschritter; Hubert Preissl; Anita M Hennige; Michael Stumvoll; Katarina Porubska; Rebekka Frost; Hannah Marx; Benjamin Klösel; Werner Lutzenberger; Niels Birbaumer; Hans-Ulrich Häring; Andreas Fritsche
Journal:  Proc Natl Acad Sci U S A       Date:  2006-07-28       Impact factor: 11.205

3.  Intranasal insulin attenuates the hypothalamic-pituitary-adrenal axis response to psychosocial stress.

Authors:  Andreas Bohringer; Lars Schwabe; Steffen Richter; Hartmut Schachinger
Journal:  Psychoneuroendocrinology       Date:  2008-09-18       Impact factor: 4.905

4.  Role of glucose and insulin resistance in development of type 2 diabetes mellitus: results of a 25-year follow-up study.

Authors:  B C Martin; J H Warram; A S Krolewski; R N Bergman; J S Soeldner; C R Kahn
Journal:  Lancet       Date:  1992-10-17       Impact factor: 79.321

5.  Central nervous insulin resistance: a promising target in the treatment of metabolic and cognitive disorders?

Authors:  M Hallschmid; B Schultes
Journal:  Diabetologia       Date:  2009-08-25       Impact factor: 10.122

Review 6.  Hypothalamic control of energy balance: different peptides, different functions.

Authors:  Sarah F Leibowitz; Katherine E Wortley
Journal:  Peptides       Date:  2004-03       Impact factor: 3.750

Review 7.  Bromocriptine: a sympatholytic, d2-dopamine agonist for the treatment of type 2 diabetes.

Authors:  Ralph A Defronzo
Journal:  Diabetes Care       Date:  2011-04       Impact factor: 19.112

8.  Intranasal insulin enhances postprandial thermogenesis and lowers postprandial serum insulin levels in healthy men.

Authors:  Christian Benedict; Swantje Brede; Helgi B Schiöth; Hendrik Lehnert; Bernd Schultes; Jan Born; Manfred Hallschmid
Journal:  Diabetes       Date:  2010-09-28       Impact factor: 9.461

Review 9.  Insulin resistance and hyperinsulinaemia in the development and progression of cancer.

Authors:  Ian F Godsland
Journal:  Clin Sci (Lond)       Date:  2009-11-23       Impact factor: 6.124

Review 10.  Where does insulin resistance start? The brain.

Authors:  Uberto Pagotto
Journal:  Diabetes Care       Date:  2009-11       Impact factor: 19.112

View more
  36 in total

Review 1.  Intranasal Insulin and Insulin-Like Growth Factor 1 as Neuroprotectants in Acute Ischemic Stroke.

Authors:  Vasileios-Arsenios Lioutas; Freddy Alfaro-Martinez; Francisco Bedoya; Chen-Chih Chung; Daniela A Pimentel; Vera Novak
Journal:  Transl Stroke Res       Date:  2015-06-05       Impact factor: 6.829

Review 2.  Insulin transport into the brain.

Authors:  Sarah M Gray; Eugene J Barrett
Journal:  Am J Physiol Cell Physiol       Date:  2018-05-30       Impact factor: 4.249

3.  Differential effect of glucose ingestion on the neural processing of food stimuli in lean and overweight adults.

Authors:  Martin Heni; Stephanie Kullmann; Caroline Ketterer; Martina Guthoff; Margarete Bayer; Harald Staiger; Fausto Machicao; Hans-Ulrich Häring; Hubert Preissl; Ralf Veit; Andreas Fritsche
Journal:  Hum Brain Mapp       Date:  2013-01-10       Impact factor: 5.038

4.  Variation in the obesity risk gene FTO determines the postprandial cerebral processing of food stimuli in the prefrontal cortex.

Authors:  Martin Heni; Stephanie Kullmann; Ralf Veit; Caroline Ketterer; Sabine Frank; Fausto Machicao; Harald Staiger; Hans-Ulrich Häring; Hubert Preissl; Andreas Fritsche
Journal:  Mol Metab       Date:  2013-12-08       Impact factor: 7.422

Review 5.  Impaired insulin action in the human brain: causes and metabolic consequences.

Authors:  Martin Heni; Stephanie Kullmann; Hubert Preissl; Andreas Fritsche; Hans-Ulrich Häring
Journal:  Nat Rev Endocrinol       Date:  2015-10-13       Impact factor: 43.330

6.  Maternal insulin sensitivity is associated with oral glucose-induced changes in fetal brain activity.

Authors:  Katarzyna Linder; Franziska Schleger; Caroline Ketterer; Louise Fritsche; Isabelle Kiefer-Schmidt; Anita Hennige; Hans-Ulrich Häring; Hubert Preissl; Andreas Fritsche
Journal:  Diabetologia       Date:  2014-03-28       Impact factor: 10.122

7.  Resting-state functional connectivity of the human hypothalamus.

Authors:  Stephanie Kullmann; Martin Heni; Katarzyna Linder; Stephan Zipfel; Hans-Ulrich Häring; Ralf Veit; Andreas Fritsche; Hubert Preissl
Journal:  Hum Brain Mapp       Date:  2014-08-14       Impact factor: 5.038

Review 8.  Intranasal insulin therapy for cognitive impairment and neurodegeneration: current state of the art.

Authors:  Suzanne M de la Monte
Journal:  Expert Opin Drug Deliv       Date:  2013-11-12       Impact factor: 6.648

9.  Intranasal insulin suppresses systemic but not subcutaneous lipolysis in healthy humans.

Authors:  K Alexander Iwen; Thomas Scherer; Martin Heni; Friedhelm Sayk; Toni Wellnitz; Felix Machleidt; Hubert Preissl; Hans-Ulrich Häring; Andreas Fritsche; Hendrik Lehnert; Christoph Buettner; Manfred Hallschmid
Journal:  J Clin Endocrinol Metab       Date:  2013-01-01       Impact factor: 5.958

10.  Intranasal insulin enhanced resting-state functional connectivity of hippocampal regions in type 2 diabetes.

Authors:  Hui Zhang; Ying Hao; Bradley Manor; Peter Novak; William Milberg; Jue Zhang; Jing Fang; Vera Novak
Journal:  Diabetes       Date:  2014-09-23       Impact factor: 9.461

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.